YHNAR

YHNAR
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $0 ▼ | $518.652K ▲ | 0% | $-0.02 ▼ | $0 ▲ |
| Q2-2025 | $0 | $668.321K ▲ | $-24.75K ▼ | 0% | $-0.003 ▼ | $-668.321K ▼ |
| Q1-2025 | $0 | $92.418K ▼ | $547.299K ▲ | 0% | $0.09 ▲ | $-92.418K ▲ |
| Q4-2024 | $0 | $179.332K ▲ | $520.426K ▲ | 0% | $0.011 ▲ | $-179.332K ▼ |
| Q3-2024 | $0 | $65.805K | $23.722K | 0% | $0.003 | $-65.805K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $63.119M ▲ | $63.17M ▲ | $1.945M ▲ | $-1.799M ▼ |
| Q2-2025 | $62.42M ▲ | $62.473M ▲ | $1.767M ▲ | $60.706M ▼ |
| Q1-2025 | $537.012K ▼ | $62.36M ▲ | $1.629M ▲ | $60.731M ▲ |
| Q4-2024 | $669.25K ▼ | $61.809M ▲ | $1.625M ▲ | $60.184M ▲ |
| Q3-2024 | $837.818K | $61.227M | $1.564M | $59.663M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $518.652K ▲ | $-136.707K ▲ | $0 | $184K ▲ | $47.293K ▲ | $-136.707K ▲ |
| Q2-2025 | $-24.75K ▼ | $-619.163K ▼ | $0 | $130K ▲ | $-489.163K ▼ | $-619.163K ▼ |
| Q1-2025 | $547.299K ▲ | $-168.238K ▲ | $0 | $36K ▼ | $-132.238K ▲ | $-168.238K ▲ |
| Q4-2024 | $520.426K ▲ | $-228.627K ▼ | $0 ▲ | $60.059K ▼ | $-168.568K ▼ | $-228.627K ▼ |
| Q3-2024 | $23.722K | $-23.978K | $-60.3M | $61.14M | $816.257K | $-23.978K |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
YHNAR today is not an operating business; it is a SPAC right tied to a planned merger, so its current financial statements mostly show an empty shell with minimal activity. The core investment story, risks, and opportunities all sit in the future combined company, centered on Zhejiang Xiaojianren’s digital fitness and health platform in China. There is an appealing narrative around AI-driven personalization, local network effects, and expansion within a large and growing health market, but also high execution risk, intense competition, and limited public visibility into financial performance. Overall, this is a very early-stage, story-driven situation where outcomes will depend far more on successful merger completion, product adoption, and scaling than on today’s reported numbers.
About YHN Acquisition I Limited Right
https://yhn-acq.comYHN Acquisition I Ltd. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on December 18, 2023 and is headquartered in Hong Kong.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $0 ▼ | $518.652K ▲ | 0% | $-0.02 ▼ | $0 ▲ |
| Q2-2025 | $0 | $668.321K ▲ | $-24.75K ▼ | 0% | $-0.003 ▼ | $-668.321K ▼ |
| Q1-2025 | $0 | $92.418K ▼ | $547.299K ▲ | 0% | $0.09 ▲ | $-92.418K ▲ |
| Q4-2024 | $0 | $179.332K ▲ | $520.426K ▲ | 0% | $0.011 ▲ | $-179.332K ▼ |
| Q3-2024 | $0 | $65.805K | $23.722K | 0% | $0.003 | $-65.805K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $63.119M ▲ | $63.17M ▲ | $1.945M ▲ | $-1.799M ▼ |
| Q2-2025 | $62.42M ▲ | $62.473M ▲ | $1.767M ▲ | $60.706M ▼ |
| Q1-2025 | $537.012K ▼ | $62.36M ▲ | $1.629M ▲ | $60.731M ▲ |
| Q4-2024 | $669.25K ▼ | $61.809M ▲ | $1.625M ▲ | $60.184M ▲ |
| Q3-2024 | $837.818K | $61.227M | $1.564M | $59.663M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $518.652K ▲ | $-136.707K ▲ | $0 | $184K ▲ | $47.293K ▲ | $-136.707K ▲ |
| Q2-2025 | $-24.75K ▼ | $-619.163K ▼ | $0 | $130K ▲ | $-489.163K ▼ | $-619.163K ▼ |
| Q1-2025 | $547.299K ▲ | $-168.238K ▲ | $0 | $36K ▼ | $-132.238K ▲ | $-168.238K ▲ |
| Q4-2024 | $520.426K ▲ | $-228.627K ▼ | $0 ▲ | $60.059K ▼ | $-168.568K ▼ | $-228.627K ▼ |
| Q3-2024 | $23.722K | $-23.978K | $-60.3M | $61.14M | $816.257K | $-23.978K |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
YHNAR today is not an operating business; it is a SPAC right tied to a planned merger, so its current financial statements mostly show an empty shell with minimal activity. The core investment story, risks, and opportunities all sit in the future combined company, centered on Zhejiang Xiaojianren’s digital fitness and health platform in China. There is an appealing narrative around AI-driven personalization, local network effects, and expansion within a large and growing health market, but also high execution risk, intense competition, and limited public visibility into financial performance. Overall, this is a very early-stage, story-driven situation where outcomes will depend far more on successful merger completion, product adoption, and scaling than on today’s reported numbers.

CEO
Man Ka Poon
Compensation Summary
(Year 2024)

CEO
Man Ka Poon
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : C+
Institutional Ownership

HARRADEN CIRCLE INVESTMENTS, LLC
1.125M Shares
$157.433K

HIGHBRIDGE CAPITAL MANAGEMENT LLC
655.825K Shares
$91.816K

AQR ARBITRAGE LLC
535.136K Shares
$74.919K

RIVERNORTH CAPITAL MANAGEMENT, LLC
445K Shares
$62.3K

TORONTO DOMINION BANK
437.17K Shares
$61.204K

HGC INVESTMENT MANAGEMENT INC.
344.188K Shares
$48.186K

CLEAR STREET GROUP INC.
324.492K Shares
$45.429K

POLAR ASSET MANAGEMENT PARTNERS INC.
290K Shares
$40.6K

BOOTHBAY FUND MANAGEMENT, LLC
233K Shares
$32.62K

ATW SPAC MANAGEMENT LLC
233K Shares
$32.62K

WOLVERINE ASSET MANAGEMENT LLC
203K Shares
$28.42K

CABLE CAR CAPITAL LLC
171K Shares
$23.94K

METEORA CAPITAL, LLC
153K Shares
$21.42K

UBS GROUP AG
42.404K Shares
$5.937K

BULLDOG INVESTORS, LLP
35.923K Shares
$5.029K

HRT FINANCIAL LP
10.952K Shares
$1.533K
Summary
Only Showing The Top 16

